PharmiWeb.com - Global Pharma News & Resources
03-Jul-2019

Anticholinergic Drugs Market is expected to register a CAGR of 4.50% to reach USD 7,149.90 Million till 2024

Global Anticholinergic Drugs Market is expected to register a CAGR of 4.50% to reach USD 7,149.90 Million till 2024.

The Global Anticholinergic Drugs Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2017 to 2024. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2017 to 2024.

We can provide sample pages for a better understanding of this report.
Request Sample of This Report @ http://www.amecoresearch.com/sample/12946

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the Global Anticholinergic Drugs Market.

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market.

The market is studied for regions such as North America (U.S., and Canada), Europe (U.K., Germany, France, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East amp; Africa (GCC, South Africa, and Rest of Middle East amp; Africa).

Key Takeaways:

What is the market size in 2018 and the growth rate of the Global Anticholinergic Drugs Market?

What is the market drivers, restrains, opportunities governing the Global Anticholinergic Drugs Market?

Which are the largest and the fastest growing segments in the Global Anticholinergic Drugs Market?

Who are the key players operating in the market and their market position?

What is the pipeline scenario, drug pricing analysis and technological development in the market?

View Detail Report With Complete Table Of Content@ http://www.amecoresearch.com/market-report/anticholinergic-drugs-market-mrf-12946

Global Anticholinergic Drugs Market: Information by Type (Synthetic Compounds, Natural, Semi-Synthetic Compounds), Application (Overactive Bladder, Parkinsonrsquo;s Disease, Chronic Obstructive Pulmonary Disease, Muscle Spasms, Irritable Bowel Syndrome), Route of Administration (Oral, Parenteral, Topical), End User (Hospitals and Pharmacies) and Region - Forecast till 2024

Market Overview

The Global Anticholinergic Drugs Market is expected to register a CAGR of 4.50% to reach USD 7,149.90 Million till 2024. Anticholinergics drugs are a broad class of drugs that block acetylcholine-mediated neurotransmission in the smooth muscle, heart, central, and peripheral nervous systems. Acetylcholine is a neurotransmitter, or a chemical messenger released by nerve cells to send signals to other cells.

The increasing prevalence of chronic diseases and increasing investments and funding in the field of life science research has led to the growth of the global anticholinergic drugs market in recent years. Moreover, the aging population is expected to fuel market growth. However, side-effects of anticholinergic drugs and stringent regulations are projected to hamper the growth of the market during the assessment period.

Market Dynamics

The increasing prevalence of chronic diseases is expected to drive the market growth. According to the American Urological Association in 2018, about 33 million US population have an overactive bladder. About 30% of men and 40% of women in the United States shows OAB symptoms. National Institutes of Health (NIH) in 2017 estimated that about 50,000 US population are diagnosed with Parkinsonrsquo;s disease each year.

Moreover, the rise in the older population will support the market growth of the anticholinergic drugs market. According to the World Health Organization (WHO), it is estimated that the worldrsquo;s population aged 60 years and older would nearly double from 12% to 22% by 2050. In the US, more specifically, more than 20% of the total population would be aged 65 years or over by 2030.

Segmentation

The anticholinergic drugs market, based on product type, has been segmented into synthetic compounds, natural, and semi-synthetic compounds.

The anticholinergic drugs market, based on application, has been segmented into the overactive bladder, Parkinsonrsquo;s disease, chronic obstructive pulmonary disease, muscle spasms, and irritable bowel syndrome.

On the basis of route of administration, the market is segmented into oral, parenteral, and topical.

On the basis of end user, the market is segmented into hospitals and pharmacies. The hospitals segment is expected to hold a major share with a market value of USD 4,218.6 million till 2024.

Key Players

The prominent players in the Global Anticholinergic Drugs Market are Pfizer Inc. (US), Allergan Plc (US), Astellas Pharma Inc. (Japan), Johnson amp; Johnson Services Inc. (US), Teva Pharmaceutical Industries Ltd (Israel), Sanofi (France), GlaxoSmithKline Plc (UK), Boehringer Ingelheim International GmbH (Germany), Novartis AG (Switzerland), Mylan N.V. (US) and others.

Some of the key strategies followed by players operating in the global anticholinergic drugs market were innovation and product development.

Regional Analysis

The Global Anticholinergic Drugs Market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

The Americas is expected to hold the largest share of the global anticholinergic drugs market. This owes to the rising geriatric population along with the high prevalence of CNS diseases and demand for effective therapies. The Europe market demonstrated substantial growth in the market due to the rising prevalence of bladder overactivity, increasing geriatric population, and rising healthcare expenditure. Germany held a share of 25.8% in the Western Europe anticholinergic drugs market in 2018. Asia-Pacific is estimated to be the fastest growing region in the global market due to the presence of a large number of research organizations and development of new infrastructure to support the healthcare industry. Also, the Middle East and Africa region is expected to show the least growth owing to low per capita income and lack of adequate healthcare spending.

Key Development

In February 2016, Boehringer Ingelheim International GmbH, Spiriva Respimat had available for the treatment of asthma in adults and adolescents in the US.

In May 2015, Boehringer Ingelheim International GmbH received FDA approval for Stiolto Respimat Inhalation Spray. Market Segmentation

Global Anticholinergic Drugs Market, by Type
Synthetic Compounds
Natural
Semi-synthetic Compounds

Global Anticholinergic Drugs Market, by Application
Overactive Bladder
Parkinsonrsquo;s disease
Chronic Obstructive Pulmonary Disease
Muscle Spasms
Irritable Bowel Syndrome

Global Anticholinergic Drugs Market, by Route of administration
Oral
Parenteral
Topical

Global Anticholinergic Drugs Market, by End User
Hospitals
Pharmacies

Global Anticholinergic Drugs Market, by Region
Americas
North America
US
Canada
South America
Europe
Western Europe
Germany
UK
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East amp; Africa
Middle East
Africa

Available Additional Customizations
Anticholinergic Drugs Market, Industry Trends
Anticholinergic Drugs Market, Technology Trends and Assessment

Intended Audience
Pharmaceutical Companies
Research and Development Organizations
Academic Institutes

Table Of Contents

Anticholinergic Drugs Market Research Report - Global Forecast till 2024

1 Introduction
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Global Anticholinergic Drugs Market, by Type
6 Global Anticholinergic Drugs Market, by Application
7 Global Anticholinergic Drugs Market, by Route of Administration
8 Global Anticholinergic Drugs Market, by End-User
9 Global Anticholinergic Drugs Market, by Region
10 Company Landscape
11 Company Profiles
12 Appendix

Quick Buy This Premium Report From Here: http://www.amecoresearch.com/buy/12946

About Us:

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:

Email: sales@amecoresearch.com | +1 407 915 4157

Editor Details

Last Updated: 03-Jul-2019